Improving Treatment of Patients Across Malignancies Through FLASCO
Winston Tan, MD, discusses the work of the Florida Society for Clinical Oncology, which helps improve the treatment of patients with all cancers.
Winston Tan, MD, hematologist/oncologist, Mayo Clinic, and vice president of the Florida Society for Clinical Oncology (FLASCO), discusses the work of FLASCO, which helps improve the treatment of patients with all cancers across the state.
Working to improve patient care, FLASCO advocates for patients with cancer throughout Florida and encourages patient support groups as well. Additionally, the organization has been actively training healthcare professionals across multiple disciplines, including nurse practitioners, hematologists, and oncologists. Symposia are another component of education from FLASCO. The symposia occur around the state and educate people on the various disease states and treatment options.
Enasidenib Shows Promise as Post-Transplant Maintenance in IDH2-Mutated AML
January 7th 2025Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic stem cell transplant maintenance therapy for IDH2-mutated acute myeloid leukemia treatment.
Read More
Could Triapine With Lutetium 177 Dotatate Improve Outcomes for Neuroendocrine Tumors?
December 30th 2024Aman Chauhan, MD, highlights an ongoing phase 2 trial exploring the combination of triapine, a radiation sensitizer, with lutetium 177 dotatate for treating well-differentiated somatostatin receptor–-positive neuroendocrine tumors.
Read More
